These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22714738)

  • 21. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
    Handorf E; Crumpler N; Gross L; Giri VN
    J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
    MacInnis RJ; Severi G; Baglietto L; Dowty JG; Jenkins MA; Southey MC; Hopper JL; Giles GG
    PLoS One; 2013; 8(2):e54727. PubMed ID: 23457453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
    Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
    BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
    Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
    Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
    Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A
    Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
    Lin X; Qu L; Chen Z; Xu C; Ye D; Shao Q; Wang X; Qi J; Chen Z; Zhou F; Wang M; Wang Z; He D; Wu D; Gao X; Yuan J; Wang G; Xu Y; Wang G; Dong P; Jiao Y; Yang J; Ou-Yang J; Jiang H; Zhu Y; Ren S; Zhang Z; Yin C; Wu Q; Zheng Y; Turner AR; Tao S; Na R; Ding Q; Lu D; Shi R; Sun J; Liu F; Zheng SL; Mo Z; Sun Y; Xu J
    Prostate; 2013 Jan; 73(2):169-75. PubMed ID: 22718278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer risk variants of the HOXB genetic locus.
    Dupont WD; Breyer JP; Johnson SH; Plummer WD; Smith JR
    Sci Rep; 2021 May; 11(1):11385. PubMed ID: 34059701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
    Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C;
    Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.
    Shang Z; Zhu S; Zhang H; Li L; Niu Y
    Eur Urol; 2013 Jul; 64(1):173-6. PubMed ID: 23518396
    [No Abstract]   [Full Text] [Related]  

  • 30. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial.
    Chen Z; Greenwood C; Isaacs WB; Foulkes WD; Sun J; Zheng SL; Condreay LD; Xu J
    Carcinogenesis; 2013 Jun; 34(6):1260-4. PubMed ID: 23393222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
    Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
    Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
    Darst BF; Hughley R; Pfennig A; Hazra U; Fan C; Wan P; Sheng X; Xia L; Andrews C; Chen F; Berndt SI; Kote-Jarai Z; Govindasami K; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Huff CD; Strom SS; Isaacs WB; Park JY; Zheng W; Ostrander EA; Walsh PC; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Stanford JL; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach RJ; Gundell SM; Pooler L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Brureau L; Blot WJ; Biritwum R; Tay E; Truelove A; Niwa S; Tettey Y; Varma R; McKean-Cowdin R; Torres M; Jalloh M; Magueye Gueye S; Niang L; Ogunbiyi O; Oladimeji Idowu M; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Yeboah ED; Mensah JE; Anthony Adjei A; Diop H; Cook MB; Chanock SJ; Watya S; Eeles RA; Chiang CWK; Lachance J; Rebbeck TR; Conti DV; Haiman CA
    Eur Urol; 2022 May; 81(5):458-462. PubMed ID: 35031163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
    Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
    Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.
    Alanee S; Shah S; Vijai J; Schrader K; Hamilton R; Rau-Murthy R; Sarrel K; Manschreck C; Eastham J; Offit K
    Fam Cancer; 2013 Dec; 12(4):597-600. PubMed ID: 23475555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOXB13 mutations in a population-based, case-control study of prostate cancer.
    Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
    Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
    Wei J; Shi Z; Na R; Wang CH; Resurreccion WK; Zheng SL; Hulick PJ; Cooney KA; Helfand BT; Isaacs WB; Xu J
    Br J Cancer; 2020 Oct; 123(9):1356-1359. PubMed ID: 32830201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited Predisposition to Prostate Cancer: From Gene Discovery to Clinical Impact.
    Cooney KA
    Trans Am Clin Climatol Assoc; 2017; 128():14-23. PubMed ID: 28790484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for familial and hereditary prostate cancer.
    Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
    Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
    FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
    Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.
    Akbari MR; Anderson LN; Buchanan DD; Clendenning M; Jenkins MA; Win AK; Hopper JL; Giles GG; Nam R; Narod S; Gallinger S; Cleary SP
    Cancer Epidemiol; 2013 Aug; 37(4):424-7. PubMed ID: 23541221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.